John Craighead | Vice President of Investor Relations and Corporate Communications |
Pascal Touchon | President and Chief Executive Officer |
AJ Joshi | Chief Medical Officer |
Chris Haqq | Chief Scientific Officer |
Anupam Rama | JP Morgan |
John Newman | Canaccord Genuity |
Salim Syed | Mizohu Americas |
Matt Phipps | William Blair |
Philip Nadeau | Cowen and Company |
Tony Butler | Roth Capital |
Yigal Nochomovitz | Citi |
Ben Burnett | Stifel |
Good day, ladies and gentlemen, and welcome to the Atara Biotherapeutics second quarter 2019 financial results conference call. At this time, all participants are listen-only mode. Later we will conduct a question and answer session. Instruction will follow at that time. [Operator Instructions] I will now like to turn the conference over to your host, Dr.